ALEYAMMA JACOB: Open Payments
NPI 1932153996 · WESTBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,919 in 84 payments from 16 companies in 2025. Trend: 2023 $2,199 · 2024 $1,892 · 2025 $1,919
Food & beverage: $1,919
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $357 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $347 |
| AstraZeneca Pharmaceuticals LP | 15 | $308 |
| Novo Nordisk Inc | 12 | $236 |
| Amgen Inc. | 12 | $197 |
| Lilly USA, LLC | 4 | $116 |
| Ardelyx, Inc. | 4 | $96 |
| Braeburn Inc. | 2 | $48 |
| Orexo US, Inc. | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
Products named: JARDIANCE, FARXIGA, VRAYLAR, Wegovy, OTEZLA, QULIPTA, IBSRELA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
